Related Experiment Video
Updated: Oct 1, 2025
04:50
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
373
Precision medicine in rheumatoid arthritis
Kartik Bhamidipati1, Kevin Wei2
1Department of Medicine, Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, USA.
Best Practice & Research. Clinical Rheumatology
|March 6, 2022
Summary
Advanced cellular profiling reveals new insights into rheumatoid arthritis (RA) pathology and patient heterogeneity. These findings pave the way for precision medicine approaches and novel therapeutic strategies in RA treatment.
Area of Science:
- Immunology
- Genomics
- Precision Medicine
Background:
- Rheumatoid arthritis (RA) is a debilitating autoimmune disease with significant patient morbidity.
- Cellular heterogeneity in RA joint tissues complicates treatment strategies.
- Novel pathogenic cell types in RA have been identified.
Purpose of the Study:
- To review novel insights into rheumatoid arthritis (RA) pathology.
- To discuss the translation of cellular discoveries into precision medicine for RA.
- To explore biomarker identification and therapeutic target validation.
Main Methods:
- Single-cell transcriptomics
- Spatial transcriptomics
- Review of current literature and research efforts
Main Results:
- Identification of novel pathogenic cell types in RA joint tissues.
- Demonstration of significant cellular composition heterogeneity among RA patients.
- Progress in identifying surrogate biomarkers for predicting RA synovial tissue phenotypes and therapy response.
Conclusions:
- Cellular profiling techniques offer new opportunities for precision medicine in RA.
- Translating discoveries into clinical practice requires identifying predictive biomarkers.
- Patient-derived organoid systems show promise for validating novel therapeutic targets in RA.
Related Concept Videos
01:21Rheumatic Heart Disease III: Medical Management
48
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
48
01:11Genome-wide Association Studies-GWAS
14.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.5K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
249
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
249
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
282
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
282
01:29Inflammatory Bowel Disease IV: Pharmacological Management
220
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
220
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
96
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
96